Two Sigma Investments
TPST icon

Two Sigma Investments’s Tempest Therapeutics TPST Stock Holding History

Two Sigma Investments’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,763
Closed -$32.1K – 3491
2024
Q3 		$32.1K Buy
+1,763
New +$36.1K ﹤0.01% 2995
2024
Q1 		– Sell
-7,709
Closed -$441K – 3395
2023
Q4 		$441K Buy
7,709
+6,660
+635% +$315K ﹤0.01% 2528
2023
Q3 		$4.15K Sell
1,049
-180
-15% -$1.73K ﹤0.01% 2917
2023
Q2 		$20.3K Buy
+1,229
New +$30.9K ﹤0.01% 2905
2021
Q2 		– Sell
-486
Closed -$114K – 4561
2021
Q1 		$114K Buy
486
+31
+7% +$12.5K ﹤0.01% 3698
2020
Q4 		$190K Buy
+455
New +$157K ﹤0.01% 3122
2018
Q4 		– Sell
-12
Closed -$25K – 3529
2018
Q3 		$25K Sell
12
-12
-50% -$28.8K ﹤0.01% 3111
2018
Q2 		$65K Buy
24
+12
+100% +$31.6K ﹤0.01% 3224
2018
Q1 		$28K Sell
12
-71
-86% -$213K ﹤0.01% 3074
2017
Q4 		$342K Buy
+83
New +$348K ﹤0.01% 2666
2015
Q2 		– Sell
-6
Closed -$579K – 3090
2015
Q1 		$579K Buy
+6
New +$799K ﹤0.01% 1885

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Two Sigma Investments's TPST Position: Q4 2024 in Review

Two Sigma Investments sold out of Tempest Therapeutics (TPST) in Q4 2024, closing a stake of 1,763 shares — an estimated $32.1K sold.

Two Sigma Investments first reported a position in TPST in Q1 2015 and held it in 11 quarters. The position peaked at $579K in Q1 2015. 33 funds tracked by Wall St. Rank hold TPST as of Q4 2024.

  • Two Sigma Investments reported no remaining Tempest Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 1,763 Tempest Therapeutics shares in Q4 2024, an estimated $32.1K.
  • Two Sigma Investments first reported a position in Tempest Therapeutics in Q1 2015 and held it in 11 quarters.
  • Two Sigma Investments's Tempest Therapeutics position peaked at $579K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.